Hadassah Medical Organization and Bar-Ilan University Collaborate with Immix BioPharma for the Further Development and Commercialization of Next-Generation CAR-T Therapy

/PRNewswire/ -- Hadasit, the Innovation Engine of Hadassah Medical Organization and BIRAD, the Commercialization arm of Bar-Ilan University announced today...

Related Keywords

Jerusalem ,Israel General ,Israel ,Ramat Gan ,Tel Aviv ,Israeli ,Tsipi Haitovsky ,Cyrillej Cohen ,Zohar Yinon ,Prnewswire Hadasit ,Ortal Harush ,Polina Stepensky ,Shlomit Kfir Erenfeld ,Nathalie Asherie ,Yoram Weiss ,Hadasit Bio ,Department Of Bone Marrow Transplantation ,Hadasit Medical Research Services ,Hadassah Medical Center ,Ilan University ,Immunotherapy Lab At Bar ,Israel Ministry Of Health ,Hadassah Medical Organization ,Division Of Scientific Services ,Institute Of Nanotechnology ,Innovation Engine Of Hadassah Medical Organization ,Life Sciences ,Hadassah University Medical Center ,Research Development Company Ltd ,Innovation Engine ,Bar Ilan University ,Immix Biopharma ,Hadassah Medical ,Bone Marrow Transplantation ,Tumor Immunology ,Medical Organization ,Director General ,Advanced Materials ,Hadasit Bio Holdings ,Development Company ,Jewish Studies ,Exact Sciences ,Social Sciences ,Hadasit ,